Albert Oriol Rocafiguera, Marek Hus, Raimundo Gazitua, Aijun Liao, Wojciech Janowski, Cindy Lee, Gabor Mikala, Artur Jurczyszyn, Alejandro Berkovits, Jin Lu, Fredrik Schjesvold, Silvia Ling, Andrew Spencer, Sikander Ailawadhi, Tondre T. Buck, Umer Khan, Florence Suzan, Maya Stefanova-Urena, Vania Hungria, Ivan Špička. "Isatuximab plus pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: Subgroup analysis by prior anti-CD38 exposure from the phase 3 IRAKLIA trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7516